Ultragenyx Pharmaceutical Inc. (RARE)
USD 39.3
(0.85%)
USD 39.3
(0.85%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.49 Billion USD | -3.52% |
| 2022 | 1.54 Billion USD | 1.51% |
| 2021 | 1.52 Billion USD | -13.48% |
| 2020 | 1.75 Billion USD | 54.96% |
| 2019 | 1.13 Billion USD | 57.8% |
| 2018 | 719.55 Million USD | 46.62% |
| 2017 | 490.75 Million USD | -9.23% |
| 2016 | 540.62 Million USD | -3.39% |
| 2015 | 559.56 Million USD | 182.66% |
| 2014 | 197.96 Million USD | 231.89% |
| 2013 | 59.64 Million USD | -32.46% |
| 2012 | 88.31 Million USD | 628.14% |
| 2011 | 12.12 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.61 Billion USD | 23.82% |
| 2024 Q1 | 1.3 Billion USD | -12.34% |
| 2023 Q2 | 1.31 Billion USD | -5.21% |
| 2023 Q1 | 1.38 Billion USD | -10.49% |
| 2023 FY | 1.49 Billion USD | -3.52% |
| 2023 Q4 | 1.49 Billion USD | 20.42% |
| 2023 Q3 | 1.23 Billion USD | -5.58% |
| 2022 Q2 | 1.32 Billion USD | -4.58% |
| 2022 Q3 | 1.61 Billion USD | 22.55% |
| 2022 FY | 1.54 Billion USD | 1.51% |
| 2022 Q4 | 1.54 Billion USD | -4.51% |
| 2022 Q1 | 1.38 Billion USD | -9.09% |
| 2021 Q4 | 1.52 Billion USD | 2.53% |
| 2021 Q3 | 1.48 Billion USD | -1.83% |
| 2021 Q2 | 1.51 Billion USD | -5.34% |
| 2021 FY | 1.52 Billion USD | -13.48% |
| 2021 Q1 | 1.59 Billion USD | -9.2% |
| 2020 Q1 | 1.23 Billion USD | 8.6% |
| 2020 Q4 | 1.75 Billion USD | 38.72% |
| 2020 Q3 | 1.26 Billion USD | -3.47% |
| 2020 Q2 | 1.31 Billion USD | 6.56% |
| 2020 FY | 1.75 Billion USD | 54.96% |
| 2019 Q2 | 958.92 Million USD | -4.85% |
| 2019 FY | 1.13 Billion USD | 57.8% |
| 2019 Q1 | 1 Billion USD | 40.05% |
| 2019 Q3 | 879.94 Million USD | -8.24% |
| 2019 Q4 | 1.13 Billion USD | 29.04% |
| 2018 Q1 | 817.35 Million USD | 66.55% |
| 2018 Q4 | 719.55 Million USD | -5.96% |
| 2018 FY | 719.55 Million USD | 46.62% |
| 2018 Q3 | 765.14 Million USD | -5.07% |
| 2018 Q2 | 806.02 Million USD | -1.39% |
| 2017 FY | 490.75 Million USD | -9.23% |
| 2017 Q2 | 497.54 Million USD | -8.85% |
| 2017 Q3 | 435.04 Million USD | -12.56% |
| 2017 Q1 | 545.82 Million USD | 0.96% |
| 2017 Q4 | 490.75 Million USD | 12.8% |
| 2016 Q1 | 524.18 Million USD | -6.32% |
| 2016 FY | 540.62 Million USD | -3.39% |
| 2016 Q2 | 481.95 Million USD | -8.06% |
| 2016 Q4 | 540.62 Million USD | 4.94% |
| 2016 Q3 | 515.16 Million USD | 6.89% |
| 2015 FY | 559.56 Million USD | 182.66% |
| 2015 Q4 | 559.56 Million USD | -7.07% |
| 2015 Q3 | 602.13 Million USD | 75.55% |
| 2015 Q2 | 343 Million USD | -3.61% |
| 2015 Q1 | 355.84 Million USD | 79.75% |
| 2014 Q1 | 172.7 Million USD | 189.54% |
| 2014 FY | 197.96 Million USD | 231.89% |
| 2014 Q4 | 197.96 Million USD | -6.15% |
| 2014 Q3 | 210.93 Million USD | 29.74% |
| 2014 Q2 | 162.58 Million USD | -5.86% |
| 2013 Q3 | 68.59 Million USD | 0.0% |
| 2013 FY | 59.64 Million USD | -32.46% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q4 | 59.64 Million USD | -13.04% |
| 2012 Q4 | 88.31 Million USD | 0.0% |
| 2012 FY | 88.31 Million USD | 628.14% |
| 2011 FY | 12.12 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -46846.253% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -131596.431% |
| XOMA Corporation | 234.3 Million USD | -536.366% |
| Mesoblast Limited | 669.15 Million USD | -122.821% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -337.506% |
| Aptorum Group Limited | 20.64 Million USD | -7123.868% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -73231.586% |
| HilleVax, Inc. | 344.43 Million USD | -332.888% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -163.271% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -5173.742% |
| Precision BioSciences, Inc. | 159.78 Million USD | -833.16% |
| Dyadic International, Inc. | 8.21 Million USD | -18040.53% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -8521.064% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -129.628% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -4597.583% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -1426.348% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -319.786% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -125.524% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -774.417% |
| IGM Biosciences, Inc. | 423.41 Million USD | -252.143% |
| Opthea Limited | 188.79 Million USD | -689.768% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -1882.045% |
| Abeona Therapeutics Inc. | 64 Million USD | -2229.635% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -865.326% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -78.979% |
| NextCure, Inc. | 129.41 Million USD | -1052.091% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -10178.137% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -935.233% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -1880.939% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -247.23% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -786.589% |
| Senti Biosciences, Inc. | 119.48 Million USD | -1147.877% |
| Apollomics, Inc. | 55.38 Million USD | -2591.991% |
| PureTech Health plc | 693.97 Million USD | -114.852% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -3959.498% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -595.092% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -158.965% |
| ChromaDex Corporation | 54.96 Million USD | -2612.708% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -20199.261% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -516.878% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -801.895% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -18587.572% |
| Gritstone bio, Inc. | 177.76 Million USD | -738.736% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -15385.662% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -194.54% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -1923.029% |
| Fortress Biotech, Inc. | 167.52 Million USD | -790.019% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -27624.303% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -1449.072% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -98.794% |
| Celcuity Inc. | 191.21 Million USD | -679.739% |
| ContextLogic Inc. | 423 Million USD | -252.485% |
| GH Research PLC | 226.3 Million USD | -558.866% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -824.161% |
| Cassava Sciences, Inc. | 151.66 Million USD | -883.109% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -16833.708% |
| ImmuCell Corporation | 43.8 Million USD | -3303.51% |
| Amarin Corporation plc | 831.68 Million USD | -79.276% |
| TG Therapeutics, Inc. | 329.58 Million USD | -352.388% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -912.517% |
| Acelyrin, Inc. | 742.69 Million USD | -100.758% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -25290.782% |
| Seer, Inc. | 436.26 Million USD | -241.765% |
| Novavax, Inc. | 1.85 Billion USD | 19.637% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -260.286% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 86.913% |
| AnaptysBio, Inc. | 452.38 Million USD | -229.586% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -5901.985% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -491.315% |
| AbCellera Biologics Inc. | 1.48 Billion USD | -0.196% |
| CorMedix Inc. | 82.05 Million USD | -1716.98% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -388.777% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -8605.43% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 95.493% |
| Aptose Biosciences Inc. | 12.92 Million USD | -11438.076% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -6642.307% |
| Soligenix, Inc. | 9.79 Million USD | -15118.571% |
| Century Therapeutics, Inc. | 360.69 Million USD | -313.377% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -94.763% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -28741.378% |
| Kura Oncology, Inc. | 448.93 Million USD | -232.122% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -760.221% |
| Ardelyx, Inc. | 297.57 Million USD | -401.048% |
| Ainos, Inc. | 31.84 Million USD | -4582.564% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -447.866% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -1244.329% |
| Prothena Corporation plc | 696.38 Million USD | -114.108% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -626.788% |
| Autolus Therapeutics plc | 375.38 Million USD | -297.2% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -492.528% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -427.576% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -2934.709% |
| Celularity Inc. | 143.88 Million USD | -936.224% |
| Rallybio Corporation | 115.62 Million USD | -1189.581% |
| GRI Bio, Inc. | 2.95 Million USD | -50340.223% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -13959.229% |
| Omeros Corporation | 378.26 Million USD | -294.167% |
| INmune Bio, Inc. | 57 Million USD | -2515.766% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -570.1% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -1676.258% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -5609.006% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -21561.641% |
| Humacyte, Inc. | 128.22 Million USD | -1062.828% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -800.892% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -136.818% |
| Immunocore Holdings plc | 597 Million USD | -149.751% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -4669.868% |
| Verastem, Inc. | 149.71 Million USD | -895.881% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -191.126% |
| Histogen Inc. | 19.07 Million USD | -7717.402% |
| Surrozen, Inc. | 46.08 Million USD | -3135.705% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -42.103% |
| Organovo Holdings, Inc. | 6.34 Million USD | -23384.218% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -34505.349% |
| IO Biotech, Inc. | 150.71 Million USD | -889.273% |
| MEI Pharma, Inc. | 41.37 Million USD | -3503.657% |
| GT Biopharma, Inc. | 14.1 Million USD | -10467.815% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -310.782% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -8140.192% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -487.823% |
| Summit Therapeutics Inc. | 202.94 Million USD | -634.674% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -17944.451% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -772.407% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -11722.44% |
| Turnstone Biologics Corp. | 112.81 Million USD | -1221.644% |
| Pulmatrix, Inc. | 33.95 Million USD | -4290.756% |
| Synaptogenix, Inc. | 31.11 Million USD | -4692.148% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -12137.467% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -172.052% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -958.522% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -14.607% |
| Cytokinetics, Incorporated | 824.31 Million USD | -80.879% |
| Exelixis, Inc. | 2.94 Billion USD | 49.326% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -309.013% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -89.04% |
| Evogene Ltd. | 51.1 Million USD | -2817.777% |
| Replimune Group, Inc. | 487.72 Million USD | -205.71% |
| PDS Biotechnology Corporation | 59.39 Million USD | -2410.542% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -15561.444% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -1463.234% |
| ESSA Pharma Inc. | 149.12 Million USD | -899.86% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -8247.276% |
| BioLineRx Ltd. | 63.92 Million USD | -2232.441% |
| Avid Bioservices, Inc. | 336.55 Million USD | -343.019% |
| Insmed Incorporated | 1.32 Billion USD | -12.12% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -1105.804% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -165.292% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -1441.593% |
| MediWound Ltd. | 66.45 Million USD | -2143.508% |
| MiMedx Group, Inc. | 239.04 Million USD | -523.732% |
| OmniAb, Inc. | 401.98 Million USD | -270.913% |
| Alector, Inc. | 621.82 Million USD | -139.779% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -315.787% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | 21.657% |
| Mereo BioPharma Group plc | 66.49 Million USD | -2142.159% |
| Zai Lab Limited | 1.03 Billion USD | -43.879% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -211.631% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -143.28% |
| Aura Biosciences, Inc. | 255.07 Million USD | -484.539% |
| Immunic, Inc. | 54.29 Million USD | -2645.931% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -803.195% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -460.06% |
| Veracyte, Inc. | 1.13 Billion USD | -31.041% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -12511.355% |
| FibroGen, Inc. | 423.52 Million USD | -252.045% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -42342.727% |
| Allakos Inc. | 243.61 Million USD | -512.049% |
| scPharmaceuticals Inc. | 94.47 Million USD | -1478.142% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -478.598% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -139.899% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -31378.517% |
| NLS Pharmaceutics AG | 1.84 Million USD | -80641.898% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -27361.443% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -188.144% |
| Precigen, Inc. | 151.04 Million USD | -887.145% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 65.78% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -533.385% |
| Incyte Corporation | 6.78 Billion USD | 78.015% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -235973.675% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -1084.811% |
| XBiotech Inc. | 227.24 Million USD | -556.132% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -868.8% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -1463.234% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -7779.088% |
| CRISPR Therapeutics AG | 2.22 Billion USD | 33.126% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -156.951% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -1249.712% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -945.591% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -421.486% |
| Agenus Inc. | 313.91 Million USD | -374.977% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -10773.885% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -1066.047% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -290.319% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -308.674% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -48246.945% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -188.419% |
| UroGen Pharma Ltd. | 178.31 Million USD | -736.187% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -7912.179% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -216.741% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -13814.947% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -2626.1% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -6631.092% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -552.974% |
| Chimerix, Inc. | 212.77 Million USD | -600.75% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -1287.815% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -4515.996% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -19055.407% |
| Pluri Inc. | 39.52 Million USD | -3672.138% |
| Cue Biopharma, Inc. | 61.53 Million USD | -2323.229% |
| MeiraGTx Holdings plc | 458.16 Million USD | -225.429% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -6482.788% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -17401.693% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -2075.708% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -8162.768% |
| CalciMedica, Inc. | 12.18 Million USD | -12136.463% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -379.371% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -163.757% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -5392.57% |
| NLS Pharmaceutics AG | 1.84 Million USD | -80641.898% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -1045.268% |
| Nutriband Inc. | 7.51 Million USD | -19734.807% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -1788.458% |
| Vor Biopharma Inc. | 209.82 Million USD | -610.588% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 79.356% |
| ProKidney Corp. | 420.55 Million USD | -254.537% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -2619.189% |
| Daré Bioscience, Inc. | 21.28 Million USD | -6905.911% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -172.889% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -18339.439% |
| Bicycle Therapeutics plc | 595.34 Million USD | -150.446% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -270.376% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -5187.28% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | 28.612% |
| Atai Life Sciences N.V. | 293.47 Million USD | -408.049% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -814.006% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -1070.175% |
| MediciNova, Inc. | 66.26 Million USD | -2149.907% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -1595.335% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -33313.067% |
| GeoVax Labs, Inc. | 9.28 Million USD | -15961.379% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -316.541% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -153.472% |
| Biomea Fusion, Inc. | 199.92 Million USD | -645.779% |
| RenovoRx, Inc. | 1.46 Million USD | -101606.207% |
| Erasca, Inc. | 395.29 Million USD | -277.188% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -207.365% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -20282.953% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -338.674% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -183.289% |
| bluebird bio, Inc. | 619.16 Million USD | -140.812% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -436.929% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -3754.739% |
| Imunon, Inc. | 21.91 Million USD | -6702.666% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 78.207% |
| BioAtla, Inc. | 119.65 Million USD | -1146.062% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -131.943% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -1454.191% |
| DBV Technologies S.A. | 182.98 Million USD | -714.824% |
| Fortress Biotech, Inc. | 167.52 Million USD | -790.019% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -137.213% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -573.95% |
| aTyr Pharma, Inc. | 122.06 Million USD | -1121.471% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -204.025% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -9736.762% |
| Galecto, Inc. | 38.22 Million USD | -3800.419% |
| Akari Therapeutics, Plc | 4.35 Million USD | -34136.808% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -8651.446% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | 13.977% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -549.88% |
| Entera Bio Ltd. | 11.76 Million USD | -12573.294% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -88.996% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -1904.75% |
| Xencor, Inc. | 952.69 Million USD | -56.505% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -1465.993% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -1334.411% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -18373.505% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -129.938% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -48246.945% |
| Portage Biotech Inc. | 7.77 Million USD | -19067.155% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -33313.067% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -438.379% |
| OncoCyte Corporation | 74.89 Million USD | -1890.884% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -25666.459% |
| Purple Biotech Ltd. | 44.3 Million USD | -3265.566% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -4269.141% |
| Onconetix, Inc. | 88.82 Million USD | -1578.663% |
| MacroGenics, Inc. | 306.82 Million USD | -385.957% |
| Tharimmune, Inc. | 10.94 Million USD | -13521.044% |
| Genprex, Inc. | 10.67 Million USD | -13873.105% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -271.449% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -200.489% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -2663.797% |
| Prime Medicine, Inc. | 193.85 Million USD | -669.154% |
| Aditxt, Inc. | 44.57 Million USD | -3244.704% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -61359.728% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -35694.841% |
| OKYO Pharma Limited | 1.54 Million USD | -96639.624% |
| Savara Inc. | 177.56 Million USD | -739.705% |
| Curis, Inc. | 77.28 Million USD | -1829.315% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -2231.573% |
| Adagene Inc. | 115.72 Million USD | -1188.368% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -7597.14% |
| BeiGene, Ltd. | 5.8 Billion USD | 74.316% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -384.263% |
| GlycoMimetics, Inc. | 45.31 Million USD | -3190.223% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -0.24% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -34387.295% |
| SciSparc Ltd. | 11.18 Million USD | -13234.046% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -34387.295% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -8084.734% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -12108.8% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -2520.381% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -12769.092% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -336.78% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -978.373% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 61.069% |
| ADMA Biologics, Inc. | 329.18 Million USD | -352.945% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -1171.924% |
| Clene Inc. | 52.34 Million USD | -2748.652% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -220.216% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -375.698% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -1047.869% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -128.089% |
| Adicet Bio, Inc. | 207.29 Million USD | -619.271% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -1043.538% |
| Absci Corporation | 234.48 Million USD | -535.881% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -33374.399% |
| Quantum-Si incorporated | 298.25 Million USD | -399.921% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -19240.89% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -324.45% |
| Surrozen, Inc. | 46.08 Million USD | -3135.705% |
| Generation Bio Co. | 374.75 Million USD | -297.86% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -485.478% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -238.123% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -840.305% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -291.952% |
| Invivyd, Inc. | 229.18 Million USD | -550.583% |
| Cingulate Inc. | 3.49 Million USD | -42604.864% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -76.664% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -12152.249% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -12660.467% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -717.486% |
| Jaguar Health, Inc. | 50.76 Million USD | -2837.204% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -7200.299% |
| 2seventy bio, Inc. | 565.42 Million USD | -163.697% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -4283.012% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -455.277% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -99.079% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -2438.572% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -1339.047% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -1428.428% |
| Kronos Bio, Inc. | 213.27 Million USD | -599.09% |
| Innoviva, Inc. | 1.24 Billion USD | -19.904% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -833.143% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -217.783% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -514.716% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | 23.931% |
| Evaxion Biotech A/S | 12.88 Million USD | -11468.447% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -491.531% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -98.092% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -560.158% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -8866.342% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -2169.772% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -1084.359% |
| Clearmind Medicine Inc. | 4.32 Million USD | -34379.16% |
| AlloVir, Inc. | 190.79 Million USD | -681.47% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -485.432% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -215.955% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -17317.135% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -304.628% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -302.949% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -23186.163% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -134.675% |
| ImmunityBio, Inc. | 504.45 Million USD | -195.571% |
| Korro Bio, Inc. | 221.66 Million USD | -572.649% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -296.071% |
| Kineta, Inc. | 10.28 Million USD | -14402.607% |
| Lantern Pharma Inc. | 43.64 Million USD | -3316.024% |
| BioVie Inc. | 25.2 Million USD | -5814.76% |
| Codexis, Inc. | 136.56 Million USD | -991.829% |
| Celularity Inc. | 143.88 Million USD | -936.224% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -1084.34% |
| Virax Biolabs Group Limited | 5.48 Million USD | -27088.575% |
| Kodiak Sciences Inc. | 479.37 Million USD | -211.035% |
| Cibus, Inc. | 544.41 Million USD | -173.876% |
| Annexon, Inc. | 297.67 Million USD | -400.888% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -984.618% |
| Moderna, Inc. | 18.42 Billion USD | 91.908% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 50.135% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -761.807% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -7002.429% |
| Immix Biopharma, Inc. | 19.92 Million USD | -7383.067% |
| Eyenovia, Inc. | 28.77 Million USD | -5080.839% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -546.782% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -390.86% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -442.287% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -20539.715% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -2347.252% |
| Alkermes plc | 2.13 Billion USD | 30.203% |
| Arcellx, Inc. | 825.13 Million USD | -80.7% |
| Moolec Science SA | 24.05 Million USD | -6099.306% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -1726.394% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -1365.945% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -222.538% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -4748.823% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -150.604% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -850.447% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -21215.975% |
| Humacyte, Inc. | 128.22 Million USD | -1062.828% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -380.778% |
| Geron Corporation | 394.07 Million USD | -278.357% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -1727.289% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -80495.297% |
| Royalty Pharma plc | 16.38 Billion USD | 90.898% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -12296.889% |
| Notable Labs, Ltd. | 19.54 Million USD | -7530.178% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -559.565% |
| Structure Therapeutics Inc. | 482.01 Million USD | -209.328% |
| IN8bio, Inc. | 33.7 Million USD | -4323.19% |
| 89bio, Inc. | 596.26 Million USD | -150.057% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -2652.978% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -749.357% |
| Acasti Pharma Inc. | 73.3 Million USD | -1934.124% |
| Genelux Corporation | 27.89 Million USD | -5245.474% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -1567.744% |
| Liquidia Corporation | 120.43 Million USD | -1138.064% |
| Mustang Bio, Inc. | 17.74 Million USD | -8303.861% |
| Immunovant, Inc. | 666.71 Million USD | -123.637% |
| Vericel Corporation | 353.65 Million USD | -321.599% |
| Quantum-Si incorporated | 298.25 Million USD | -399.921% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -932.55% |
| XOMA Corporation | 234.3 Million USD | -536.366% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -539.404% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -32653.097% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -5609.006% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1288.435% |
| Vaxcyte, Inc. | 1.4 Billion USD | -5.902% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -54.541% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -33374.399% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -6444.985% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -2789.392% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -3192.364% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -348.095% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -725.173% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -3948.256% |
| PepGen Inc. | 143.05 Million USD | -942.287% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -3801.439% |
| United Therapeutics Corporation | 7.16 Billion USD | 79.196% |
| Solid Biosciences Inc. | 164.93 Million USD | -803.978% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -25290.782% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -20539.715% |
| Immuneering Corporation | 102.58 Million USD | -1353.448% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -34505.349% |
| Silo Pharma, Inc. | 7.74 Million USD | -19148.462% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -31133.462% |
| Belite Bio, Inc | 94.64 Million USD | -1475.424% |
| Pharming Group N.V. | 462.85 Million USD | -222.135% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -7779.088% |
| Bionomics Limited | 27.64 Million USD | -5292.629% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -758.256% |
| uniQure N.V. | 831.68 Million USD | -79.275% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -4501.04% |
| GeoVax Labs, Inc. | 9.28 Million USD | -15961.379% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -444.394% |
| Altimmune, Inc. | 210.64 Million USD | -607.849% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -36506.218% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1288.435% |
| Peak Bio, Inc. | 2.59 Million USD | -57325.835% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -42342.727% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -12513.256% |
| Benitec Biopharma Inc. | 52.21 Million USD | -2755.8% |
| Zura Bio Limited | 100.84 Million USD | -1378.549% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -91.676% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -22537.331% |
| Compugen Ltd. | 121.33 Million USD | -1128.85% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -28629.028% |
| argenx SE | 4.54 Billion USD | 67.176% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -765.223% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -7671.764% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -336.149% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -4187.847% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -132.772% |
| PolyPid Ltd. | 15.37 Million USD | -9599.538% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -1149.948% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -12992.843% |
| Forte Biosciences, Inc. | 38.98 Million USD | -3725.072% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -731.088% |
| Instil Bio, Inc. | 325.63 Million USD | -357.886% |
| Elevation Oncology, Inc. | 89.09 Million USD | -1573.584% |
| Immunome, Inc. | 148.54 Million USD | -903.779% |
| Verona Pharma plc | 308.12 Million USD | -383.9% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -24272.993% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -1614.616% |
| Shattuck Labs, Inc. | 159.56 Million USD | -834.429% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -691.173% |
| Design Therapeutics, Inc. | 289.64 Million USD | -414.776% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -1947.392% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -27419.62% |
| Achilles Therapeutics plc | 161.45 Million USD | -823.479% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -1856.402% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -2474.441% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -183.172% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -2.144% |
| Moolec Science SA | 24.05 Million USD | -6099.306% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -2841.028% |
| AEON Biopharma, Inc. | 6.84 Million USD | -21682.513% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -1025.947% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -448.435% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -91.07% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -458.444% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -762.134% |
| Athira Pharma, Inc. | 160.24 Million USD | -830.458% |
| HCW Biologics Inc. | 28.51 Million USD | -5129.118% |
| XOMA Corporation | 234.3 Million USD | -536.366% |
| NeurAxis, Inc. | 509.49 Thousand USD | -292543.543% |
| Lumos Pharma, Inc. | 40.63 Million USD | -3569.012% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -1614.616% |
| 180 Life Sciences Corp. | 5.25 Million USD | -28249.079% |
| Nektar Therapeutics | 398.03 Million USD | -274.595% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -4187.847% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -2017.08% |
| Arvinas, Inc. | 1.3 Billion USD | -14.289% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -17317.135% |
| Palisade Bio, Inc. | 14.05 Million USD | -10510.682% |
| Nutriband Inc. | 7.51 Million USD | -19734.807% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -8651.446% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -648.121% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -609.01% |
| Merus N.V. | 458.49 Million USD | -225.198% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -629.58% |
| Neurogene Inc. | 222.57 Million USD | -569.898% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -130.585% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -23940.842% |
| CervoMed Inc. | 9.97 Million USD | -14851.214% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -229.116% |
| Sesen Bio, Inc. | 189.17 Million USD | -688.17% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -727.403% |
| Rezolute, Inc. | 132.73 Million USD | -1023.284% |
| Clene Inc. | 52.34 Million USD | -2748.652% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -9890.788% |
| BeyondSpring Inc. | 24.8 Million USD | -5910.21% |
| Synlogic, Inc. | 75.55 Million USD | -1873.545% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -12469.659% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -15822.821% |
| Peak Bio, Inc. | 2.59 Million USD | -57325.835% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -752.821% |
| Krystal Biotech, Inc. | 818.35 Million USD | -82.196% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -520.124% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -105.434% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -41581.31% |
| MannKind Corporation | 475.19 Million USD | -213.767% |
| Ikena Oncology, Inc. | 192.09 Million USD | -676.197% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -11048.594% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -1179.411% |
| Gossamer Bio, Inc. | 311.91 Million USD | -378.017% |
| CohBar, Inc. | 16.36 Million USD | -9010.616% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -4140.29% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -20282.953% |
| Legend Biotech Corporation | 1.84 Billion USD | 19.344% |
| Mural Oncology plc | 301.74 Million USD | -394.13% |
| Disc Medicine, Inc. | 367.99 Million USD | -305.171% |
| Champions Oncology, Inc. | 26.13 Million USD | -5605.698% |
| REGENXBIO Inc. | 573.97 Million USD | -159.772% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -54957.836% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -865.77% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -12247.341% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -338.488% |
| Vaxart, Inc. | 91.83 Million USD | -1523.667% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -2389.009% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -905.221% |
| Cellectis S.A. | 334.27 Million USD | -346.05% |
| Longeveron Inc. | 12.17 Million USD | -12143.496% |
| Repare Therapeutics Inc. | 253.9 Million USD | -487.242% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 54.328% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -642.363% |
| Revolution Medicines, Inc. | 2.08 Billion USD | 28.612% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -91654.646% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -436.894% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -814.182% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -974.65% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -5742.07% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 93.44% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -29.213% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -12108.8% |
| Veru Inc. | 50.59 Million USD | -2846.903% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -3173.139% |
| Cingulate Inc. | 3.49 Million USD | -42604.864% |
| Passage Bio, Inc. | 150.54 Million USD | -890.41% |
| Context Therapeutics Inc. | 16.06 Million USD | -9182.435% |
| Exicure, Inc. | 11.58 Million USD | -12775.76% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -296.495% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -822.417% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -8433.728% |
| Nuvalent, Inc. | 732.38 Million USD | -103.584% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -9877.283% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -1564.932% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -10406.751% |
| OmniAb, Inc. | 401.98 Million USD | -270.913% |
| Anew Medical, Inc. | 19.45 Million USD | -7563.531% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -5478.77% |
| Lipocine Inc. | 23 Million USD | -6382.363% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -966.48% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -387.953% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -1676.258% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -1126.767% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -18690.334% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -68.996% |
| Ocugen, Inc. | 64.54 Million USD | -2209.965% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -1097.207% |
| Q32 Bio Inc. | 306.11 Million USD | -387.07% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -35332.818% |
| Alumis Inc. Common Stock | 89.61 Million USD | -1563.854% |
| Equillium, Inc. | 50.53 Million USD | -2850.748% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -1882.862% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -3512.517% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -87562.661% |
| Dominari Holdings Inc. | 57.55 Million USD | -2490.453% |
| Edesa Biotech, Inc. | 8.89 Million USD | -16670.975% |
| vTv Therapeutics Inc. | 11.01 Million USD | -13432.52% |
| Bio-Techne Corporation | 2.81 Billion USD | 46.999% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -59.106% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -83.747% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -436.983% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -3475.399% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -123.343% |
| Nkarta, Inc. | 378.88 Million USD | -293.527% |
| BioCardia, Inc. | 2.98 Million USD | -49816.739% |
| Iterum Therapeutics plc | 26.25 Million USD | -5578.103% |